Peter Kharchenko

Title: The Innovations of Peter Kharchenko

Introduction

Peter Kharchenko is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of hematopoietic stem cell research. With a total of 2 patents, his work focuses on enhancing hematopoietic reconstitution methods.

Latest Patents

Kharchenko's latest patents include innovative methods for promoting hematopoietic stem and progenitor cell expansion. One patent details the use of Embigin inhibition to enhance hematopoietic reconstitution in subjects. This method involves administering a therapeutically effective amount of an Embigin inhibitor to a recipient, which may also include the administration of hematopoietic stem/progenitor cells. Another method described in his patents involves administering an Embigin inhibitor to a donor prior to the harvest of these cells. His second patent focuses on IL-18 inhibition for promoting early hematopoietic progenitor expansion. Similar to the first, this method involves administering an IL-18 inhibitor to a recipient and potentially to a donor before cell harvest.

Career Highlights

Throughout his career, Kharchenko has worked with prestigious institutions such as The General Hospital Corporation and Harvard College. His research has contributed to advancements in the understanding and application of hematopoietic stem cell therapies.

Collaborations

Some of his notable coworkers include David T. Scadden and Lev Silberstein. Their collaborative efforts have furthered the research in hematopoietic stem cell expansion and its therapeutic applications.

Conclusion

Peter Kharchenko's innovative work in hematopoietic stem cell research has led to significant advancements in the field. His patents reflect a commitment to improving therapeutic methods for hematopoietic reconstitution.